調査レポートカテゴリー： MarketsandMarkets, 世界

Pen Needles Market by Type (Standard Pen Needles and Safety Pen Needles), Needle Length (4mm, 5mm, 6mm, 8mm, 10mm, 12mm), Therapy (Insulin, GLP-1, Growth Hormone, and Others), Mode of Purchase (Retail, Non-Retail) - Global Forecasts to 2023

ペンニードルの世界市場予測（～2023年）

◆タイトル：Pen Needles Market by Type (Standard Pen Needles and Safety Pen Needles), Needle Length (4mm, 5mm, 6mm, 8mm, 10mm, 12mm), Therapy (Insulin, GLP-1, Growth Hormone, and Others), Mode of Purchase (Retail, Non-Retail) - Global Forecasts to 2023
◆商品コード：MD 2851
◆調査・発行会社：MarketsandMarkets
◆発行日：2019年2月20日
◆ページ数：145
◆レポート形式：PDF / 英語
◆納品方法：Eメール（受注後24時間以内）
◆調査対象地域：グローバル
◆産業分野：医療機器
◆販売価格オプション（消費税別）

Single User（1名様閲覧）	USD5,650 ⇒換算￥644,100	見積依頼/購入/質問フォーム
Multi User (Five User)	USD6,650 ⇒換算￥758,100	見積依頼/購入/質問フォーム
Corporate License (全社内共有可)	USD8,150 ⇒換算￥929,100	見積依頼/購入/質問フォーム

※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※商品の納品後、納品日＋5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。（振込先：三菱東京UFJ銀行/京橋支店/H&Iグローバルリサーチ株式会社）
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※ご購入後、レポートに記載の英語表現や単語の意味に関しましては無料でお答えいたします。（但し、対応範囲は弊社で判断）
※弊社H&Iグローバルリサーチ株式会社はMarketsandMarketsの日本における正規販売代理店です。

【レポートの概要】

ペンニードルの世界市場は、2018年の推定20億米ドルから2023年には34億米ドルに達し、この期間中11.0％の年平均成長率で成長すると予測されています。この市場の成長を促す要因として、慢性疾患の罹患率の増加、特定の国々における有利な医療費償還条件、バイオ後発品に対する選好の高まりなどが考えられます。一方で、発展途上国における代替の薬物送達様式の選好や好ましくない医療費償還条件により、市場の成長は抑制されています。また、ペンニードルの再利用も市場の成長を左右する重要な課題とも言えます。当調査レポートでは、ペンニードルの世界市場について調査・分析し、エグゼクティブサマリー、市場インサイト、市場概観/市場動向、市場シェア分析、種類（標準型、安全型）分析、ニードルの長さ（4mm、5mm、6mm、8mm、10mm、12mm）分析、治療法（インスリン、GLP-1、成長ホルモン、その他）分析、購入方法（小売、小売以外）分析、ペンニードルの世界市場規模及び予測、市場動向、競争状況、関連企業分析などの情報をお届けいたします。

・イントロダクション
・エグゼクティブサマリー
・ペンニードルの世界市場：市場インサイト
・ペンニードルの世界市場：市場概観/市場動向
・ペンニードルの世界市場：市場シェア分析
・ペンニードルの世界市場：市場環境分析
・ペンニードルの世界市場：種類（標準型、安全型）分析/市場規模
・ペンニードルの世界市場：ニードルの長さ（4mm、5mm、6mm、8mm、10mm、12mm）分析/市場規模
・ペンニードルの世界市場：治療法（インスリン、GLP-1、成長ホルモン、その他）分析/市場規模
・ペンニードルの世界市場：購入方法（小売、小売以外）分析/市場規模
・ペンニードルのアジア市場規模予測
・ペンニードルのヨーロッパ市場規模予測
・ペンニードルのアメリカ市場規模予測
・ペンニードルの世界市場動向
・ペンニードルの世界市場：競争状況
・ペンニードルの世界市場：関連企業分析
...

※上記の和訳は最新内容ではない場合があります。下記の英文概要・目次が最新版です。

The pen needles market is projected to grow at a CAGR of 11% during the forecast period.The pen needles market is expected to reach 3.4 billion by 2023 from an estimated USD 2.0 billion in 2018, at a CAGR of 11.0% during the forecast period. Growth in the pen needles market is mainly driven by factors such as the growing prevalence of chronic diseases and the favorable reimbursement scenario in selected countries. The growing preference for biosimilar drugs is another factor providing a wide range of growth opportunities for key players in the market. On the other hand, the preference for alternative modes of drug delivery and the poor reimbursement scenario in developing countries are key factors restricting market growth to a certain extent. The reuse of pen needles is another key factor challenging market growth.

By type, the safety pen needles segment is expected to grow at the highest rate during the forecast period.
On the basis of type, the pen needles market is segmented into standard and safety pen needles. The safety pen needles segment is expected to grow at the highest CAGR during the forecast period as they reduce direct pressure on the skin due to their wide shield diameter.

The retail segment dominated the market in 2018.
On the basis of mode of purchase, the pen needles market is segmented into retail and non-retail. The retail segment dominated the market in 2018. This can be attributed to the significant discounts offered on the online/retail purchases of pen needles and the convenience associated with online purchases.

The Asia Pacific pen needles market is expected to grow at the highest CAGR during the forecast period.
Asia Pacific, comprising China, India, Japan, and Rest of Asia Pacific countries offers high-growth opportunities for players in the pen needles market. This segment is slated to register the highest CAGR during the forecast period. Some of the factors driving market growth in the Asia Pacific region are high patient population, rising healthcare expenditure, and increasing healthcare access.

Break of primary participants was as mentioned below:
• By Company Type – Tier 1–55%, Tier 2–25% and Tier 3–20%
• By Designation – C-level–43%, Director Level–32%, Others–25%
• By Region – North America–38%, Europe–23%, Asia Pacific–29%, RoW–10%

The key players in the pen needles market are Becton, Dickinson and Company (US), Novo Nordisk A/S (Denmark), Ypsomed Holding AG (Switzerland), B. Braun Melsungen AG (Germany), HTL-STREFA S.A. (Poland), Terumo Corporation (Japan), and Owen Mumford.
Research Coverage:
The report analyzes the pen needles market and aims at estimating the market size and future growth potential of this market based on various segments such as type, length, therapy, mode of purchase, and region. The report also includes competitive analysis of the key players in this market along with their company profiles, product offerings, recent developments, and key market strategies.

Reasons to Buy the Report
The report can help established firms as well as new entrants/smaller firms to gauge the pulse of the market, which in turn would help them garner a greater share. Firms purchasing the report could use one, or a combination of the below mentioned five strategies.

This report provides insights into the following pointers:
• Market Penetration: Comprehensive information on the services offered by the top players in the pen needles market. The report analyzes the market based on type, length, therapy, mode of purchase, and region
• Product Development/Innovation: Detailed insights on new product launches in the pen needles market
• Market Development: Comprehensive information about lucrative emerging markets. The report analyzes the markets for various pen needles across regions
• Market Diversification: Exhaustive information about solutions and services, untapped regions, recent developments, and investments in the pen needles market
• Competitive Assessment: In-depth assessment of market shares, strategies, distribution networks, and manufacturing capabilities of the leading players in the market

【レポートの目次】

TABLE OF CONTENTS

1 INTRODUCTION 15
1.1 OBJECTIVES OF THE STUDY 15
1.2 MARKET DEFINITION 15
1.3 MARKET SCOPE 16
1.3.1 MARKETS COVERED 16
1.3.2 YEARS CONSIDERED FOR THE STUDY 16
1.4 CURRENCY 17
1.5 LIMITATIONS 17
1.6 STAKEHOLDERS 17
2 RESEARCH METHODOLOGY 18
2.1 RESEARCH DATA 18
2.1.1 SECONDARY DATA 20
2.1.1.1 Key data from secondary sources 20
2.1.2 PRIMARY DATA 21
2.1.2.1 Key data from primary sources 22
2.1.2.2 Key industry insights 23
2.2 MARKET SIZE ESTIMATION 23
2.2.1 MARKET DATA VALIDATION AND TRIANGULATION 25
2.3 ASSUMPTIONS FOR THE STUDY 26
3 EXECUTIVE SUMMARY 27
4 PREMIUM INSIGHTS 31
4.1 PEN NEEDLES MARKET OVERVIEW 31
4.2 EUROPE: PEN NEEDLES MARKET, BY TYPE & COUNTRY, 2018 32
4.3 NORTH AMERICA: PEN NEEDLES MARKET, BY TYPE, 2018 33
4.4 PEN NEEDLES MARKET: GEOGRAPHIC SNAPSHOT 34
5 MARKET OVERVIEW 35
5.1 INTRODUCTION 35
5.2 MARKET DYNAMICS 35
5.2.1 DRIVERS 36
5.2.1.1 Growing prevalence of chronic diseases 36
5.2.1.2 Favorable reimbursement in selected countries 36
5.2.2 RESTRAINTS 36
5.2.2.1 Preference for alternative modes of drug delivery 36
5.2.2.2 Poor reimbursement scenario in developing countries 37

5.2.3 OPPORTUNITIES 37
5.2.3.1 Growing preference for biosimilar drugs 37
5.2.4 CHALLENGES 38
5.2.4.1 Reuse of pen needles 38
6 INDUSTRY INSIGHTS 39
6.1 INTRODUCTION 39
6.2 PORTER’S FIVE FORCES ANALYSIS 39
6.2.1 THREAT OF NEW ENTRANTS 40
6.2.2 BARGAINING POWER OF SUPPLIERS 40
6.2.3 BARGAINING POWER OF BUYERS 40
6.2.4 SEGMENT RIVALRY 40
6.2.5 THREAT OF SUBSTITUTES 41
6.3 COMPETITIVE INTENSITY 41
6.3.1 EVALUATION PARAMETERS 41
6.3.2 SCORING METHODOLOGY 43
6.3.3 COMPETITIVE INTENSITY SCORE, BY COMPANY 43
6.3.3.1 Competitive intensity score for BD 43
6.3.3.2 Competitive intensity score for Novo Nordisk 45
6.3.3.3 Competitive intensity score for Ypsomed 47
6.3.4 COMPETITIVE INTENSITY MAPPING OF BD, NOVO NORDISK, AND YPSOMED 49
6.3.5 COMPARISON OF EVALUATION PARAMETERS, BY COMPANY 51
6.3.5.1 Pricing 51
6.3.5.2 Product portfolio 51
6.3.5.3 Product launches/technological advancements 52
6.3.5.4 Geographical presence 53
6.3.5.5 Promotional/marketing activities 53
6.3.5.6 Sponsorships/Donations/Education/Awareness Campaigns 54
6.3.5.7 M&A, Partnerships, Collaborations, Agreements, and Expansions 54
6.3.5.8 Certifications/Accreditations/Awards 55
7 PEN NEEDLES MARKET, BY TYPE 56
7.1 INTRODUCTION 57
7.2 STANDARD PEN NEEDLES 58
7.2.1 STANDARD PEN NEEDLES ARE PREFERRED OVER SAFETY PEN NEEDLES AS THEY ARE MORE AFFORDABLE, CONSIDERING THE NEED FOR DAILY INSULIN INTAKE 58
7.3 SAFETY PEN NEEDLES 60
7.3.1 DEMAND FOR SAFETY PEN NEEDLES TO RISE DUE TO GROWING CONCERNS REGARDING THE PREVENTION OF NSIS ASSOCIATED WITH STANDARD NEEDLES 60

8 PEN NEEDLES MARKET, BY LENGTH 62
8.1 INTRODUCTION 63
8.2 4MM 64
8.2.1 4MM PEN NEEDLES ARE EXPECTED TO REGISTER THE HIGHEST GROWTH RATE DURING THE FORECAST PERIOD 64
8.3 5MM 64
8.3.1 5MM PEN NEEDLES TO REGISTER THE SECOND-HIGHEST GROWTH RATE DURING THE STUDY PERIOD 64
8.4 6MM 65
8.4.1 6MM PEN NEEDLES ARE THE MOST COMMONLY USED NEEDLES ACROSS THE GLOBE 65
8.5 8MM 65
8.5.1 8MM PEN NEEDLES WILL CONTINUE TO DOMINATE THE PEN NEEDLES MARKET DURING THE FORECAST PERIOD 65
8.6 10MM 66
8.6.1 AVAILABILITY OF SHORTER PEN NEEDLES TO RESTRAIN THE GROWTH OF THE 10MM PEN NEEDLES MARKET 66
8.7 12MM 67
8.7.1 POPULARITY OF SHORTER & LESS PAINFUL NEEDLES TO HAMPER THE GROWTH OF THE 12MM PEN NEEDLES MARKET 67
9 PEN NEEDLES MARKET, BY THERAPY 68
9.1 INTRODUCTION 69
9.2 INSULIN THERAPY 70
9.2.1 RISING PREVALENCE OF DIABETES TO DRIVE THE GROWTH OF THE PEN NEEDLES MARKET FOR INSULIN THERAPY 70
9.3 GLUCAGON-LIKE PEPTIDE-1 (GLP-1) THERAPY 71
9.3.1 STRONG FOCUS OF MAJOR PHARMACEUTICAL COMPANIES TO INTRODUCE GLP-1 DRUGS IN THE MARKET TO DRIVE THE GROWTH OF THE PEN NEEDLES MARKET FOR GLP-1 THERAPY 71
9.4 GROWTH HORMONE THERAPY 72
9.4.1 DEVELOPMENT OF SUSTAINED-RELEASE GROWTH HORMONE FORMULATIONS FOR REDUCING INJECTION FREQUENCY TO RESTRAIN THE GROWTH OF THE PEN NEEDLES MARKET FOR GROWTH HORMONE THERAPY 72
9.5 OTHER THERAPIES 73
10 PEN NEEDLES MARKET, BY MODE OF PURCHASE 75
10.1 INTRODUCTION 76
10.2 RETAIL 77
10.2.1 RETAIL PURCHASES OF PEN NEEDLES TO WITNESS HIGH GROWTH IN THE COMING YEARS OWING TO THE GROWING POPULARITY OF ONLINE PURCHASES 77
10.3 NON-RETAIL 78
10.3.1 THE LARGE NUMBER OF NEEDLE-PHOBIC DIABETIC PATIENTS IS SUPPORTING THE GROWTH OF THIS SEGMENT 78
11 PEN NEEDLES MARKET, BY REGION 80
11.1 INTRODUCTION 81
11.2 EUROPE 83
11.2.1 GERMANY 86
11.2.1.1 High diabetes expenditure and reimbursement for pen needles is expected to drive the market in Germany 86
11.2.2 UK 87
11.2.2.1 NHS support and access to cost-effective pen needles are likely to drive the market in the UK 87
11.2.3 FRANCE 88
11.2.3.1 Higher insurance coverage and increase in aging population and affordability contribute to demand for pen needles 88
11.2.4 ITALY 89
11.2.4.1 Wide regional variations in terms of benefits and coverage to slow growth in Italy 89
11.2.5 SPAIN 90
11.2.5.1 Supportive regulations mandating the use of safety pen needles to boost the growth of the Spanish market 90
11.2.6 REST OF EUROPE 91
11.3 NORTH AMERICA 92
11.3.1 US 95
11.3.1.1 US dominates the pen needles market in North America 95
11.3.2 CANADA 96
11.3.2.1 High diabetes prevalence and growing geriatric population will support pen needle uptake 96
11.4 ASIA PACIFIC 98
11.4.1 JAPAN 101
11.4.1.1 High diabetes incidence and approval of injectable insulin to drive the pen needles market in Japan 101
11.4.2 CHINA 102
11.4.2.1 Suboptimal insurance coverage policies will dampen market growth 102
11.4.3 INDIA 103
11.4.3.1 Low pen needle penetration, lack of awareness to restrain market growth in India 103
11.4.4 REST OF ASIA PACIFIC 104
11.5 REST OF THE WORLD 105
11.5.1 LATIN AMERICA 108
11.5.1.1 Healthcare reforms to drive growth in Mexico 108
11.5.2 MIDDLE EAST & AFRICA 109
11.5.2.1 Favorable reforms in South Africa to bolster market growth 109

12 COMPETITIVE LANDSCAPE 111
12.1 OVERVIEW 111
12.2 MARKET SHARE (AS OF 2017) 111
12.2.1 BECTON, DICKINSON AND COMPANY 112
12.2.2 NOVO NORDISK 112
12.2.3 YPSOMED 112
12.3 COMPETITIVE LEADERSHIP MAPPING (2017) 113
12.3.1 VENDOR INCLUSION CRITERIA 113
12.3.2 VISIONARY LEADERS 113
12.3.3 INNOVATORS 113
12.3.4 DYNAMIC DIFFERENTIATORS 113
12.3.5 EMERGING COMPANIES 114
12.4 COMPETITIVE SCENARIO 115
12.4.1 PRODUCT LAUNCHES 115
12.4.2 EXPANSIONS 116
12.4.3 AGREEMENTS 116
13 COMPANY PROFILES 117
(Introduction, Products & Services, Strategy, & Analyst Insights, Developments, MnM View)*
13.1 BECTON, DICKINSON AND COMPANY 117
13.2 NOVO NORDISK 119
13.3 YPSOMED 121
13.4 OWEN MUMFORD, LTD. 123
13.5 HTL-STREFA 124
13.6 B. BRAUN MELSUNGEN 125
13.7 TERUMO CORPORATION 126
13.8 ULTIMED 128
13.9 ALLISON MEDICAL, INC. 129
13.10 ARTSANA S.P.A. 130
13.11 ARKRAY, INC. 131
13.12 GLUCORX 132

*Details on MarketsandMarkets view, Introduction, Product & Services, Strategy, & Analyst Insights, New Developments might not be captured in case of unlisted companies.
14 APPENDIX 133
14.1 DISCUSSION GUIDE 133
14.2 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 141
14.3 AVAILABLE CUSTOMIZATIONS 143
14.4 RELATED REPORTS 143
14.5 AUTHOR DETAILS 144

LIST OF TABLES

TABLE 1 EVALUATION PARAMETERS & SCORES 41
TABLE 2 COMPETITIVE INTENSITY FOR BD 43
TABLE 3 COMPETITIVE INTENSITY FOR NOVO NORDISK 45
TABLE 4 COMPETITIVE INTENSITY FOR YPSOMED 47
TABLE 5 PEN NEEDLES MARKET, BY TYPE, 2016–2023 (USD MILLION) 57
TABLE 6 PEN NEEDLES MARKET, BY TYPE, 2016–2023 (MILLION UNITS) 58
TABLE 7 STANDARD PEN NEEDLES MARKET, BY REGION, 2016–2023 (USD MILLION) 59
TABLE 8 STANDARD PEN NEEDLES MARKET, BY REGION, 2016–2023 (MILLION UNITS) 59
TABLE 9 SAFETY PEN NEEDLES MARKET, BY REGION, 2016–2023 (USD MILLION) 60
TABLE 10 SAFETY PEN NEEDLES MARKET, BY REGION, 2016–2023 (THOUSAND UNITS) 61
TABLE 11 PEN NEEDLES MARKET, BY LENGTH, 2016–2023 (USD MILLION) 63
TABLE 12 4MM PEN NEEDLES MARKET, BY REGION, 2016–2023 (USD MILLION) 64
TABLE 13 5MM PEN NEEDLES MARKET, BY REGION, 2016–2023 (USD MILLION) 64
TABLE 14 6MM PEN NEEDLES MARKET, BY REGION, 2016–2023 (USD MILLION) 65
TABLE 15 8MM PEN NEEDLES MARKET, BY REGION, 2016–2023 (USD MILLION) 66
TABLE 16 10MM PEN NEEDLES MARKET, BY REGION, 2016–2023 (USD MILLION) 66
TABLE 17 12MM PEN NEEDLES MARKET, BY REGION, 2016–2023 (USD MILLION) 67
TABLE 18 PEN NEEDLES MARKET, BY THERAPY, 2016–2023 (USD MILLION) 69
TABLE 19 PEN NEEDLES MARKET FOR INSULIN THERAPY, BY REGION,
2016–2023 (USD MILLION) 70
TABLE 20 PEN NEEDLES MARKET FOR GLP-1 THERAPY, BY REGION,
2016–2023 (USD MILLION) 72
TABLE 21 PEN NEEDLES MARKET FOR GROWTH HORMONE THERAPY,
BY REGION, 2016–2023 (USD MILLION) 73
TABLE 22 PEN NEEDLES MARKET FOR OTHER THERAPIES, BY REGION,
2016–2023 (USD MILLION) 74
TABLE 23 PEN NEEDLES MARKET, BY MODE OF PURCHASE, 2016–2023 (USD MILLION) 76
TABLE 24 PEN NEEDLES MARKET FOR RETAIL PURCHASES, BY REGION,
2016–2023 (USD MILLION) 77
TABLE 25 INDICATIVE LIST OF REGULATORY ACTS 78
TABLE 26 PEN NEEDLES MARKET FOR NON-RETAIL PURCHASES, BY REGION,
2016–2023 (USD MILLION) 79
TABLE 27 PEN NEEDLES MARKET, BY REGION, 2016–2023 (USD MILLION) 82
TABLE 28 PEN NEEDLES MARKET, BY REGION, 2016–2023 (MILLION UNITS) 82
TABLE 29 EUROPE: PEN NEEDLES MARKET, BY COUNTRY, 2016–2023 (USD MILLION) 84
TABLE 30 EUROPE: PEN NEEDLES MARKET, BY COUNTRY, 2016–2023 (MILLION UNITS) 84
TABLE 31 EUROPE: PEN NEEDLES MARKET, BY TYPE, 2016–2023 (USD MILLION) 84
TABLE 32 EUROPE: PEN NEEDLES MARKET, BY TYPE, 2016–2023 (MILLION UNITS) 85
TABLE 33 EUROPE: PEN NEEDLES MARKET, BY NEEDLE LENGTH, 2016–2023 (USD MILLION) 85
TABLE 34 EUROPE: PEN NEEDLES MARKET, BY THERAPY, 2016–2023 (USD MILLION) 85
TABLE 35 EUROPE: PEN NEEDLES MARKET, BY MODE OF PURCHASE,
2016–2023 (USD MILLION) 86
TABLE 36 GERMANY: PEN NEEDLES MARKET, BY TYPE, 2016–2023 (USD MILLION) 86
TABLE 37 GERMANY: PEN NEEDLES MARKET, BY TYPE, 2016–2023 (MILLION UNITS) 87
TABLE 38 UK: PEN NEEDLES MARKET, BY TYPE, 2016–2023 (USD MILLION) 87
TABLE 39 UK: PEN NEEDLES MARKET, BY TYPE, 2016–2023 (MILLION UNITS) 88
TABLE 40 FRANCE: PEN NEEDLES MARKET, BY TYPE, 2016–2023 (USD MILLION) 88
TABLE 41 FRANCE: PEN NEEDLES MARKET, BY TYPE, 2016–2023 (MILLION UNITS) 89
TABLE 42 ITALY: PEN NEEDLES MARKET, BY TYPE, 2016–2023 (USD MILLION) 89
TABLE 43 ITALY: PEN NEEDLES MARKET, BY TYPE, 2016–2023 (MILLION UNITS) 90
TABLE 44 SPAIN: PEN NEEDLES MARKET, BY TYPE, 2016–2023 (USD MILLION) 90
TABLE 45 SPAIN: PEN NEEDLES MARKET, BY TYPE, 2016–2023 (MILLION UNITS) 91
TABLE 46 ROE: PEN NEEDLES MARKET, BY TYPE, 2016–2023 (USD MILLION) 91
TABLE 47 ROE: PEN NEEDLES MARKET, BY TYPE, 2016–2023 (MILLION UNITS) 91
TABLE 48 NORTH AMERICA: PEN NEEDLES MARKET, BY COUNTRY,
2016–2023 (USD MILLION) 93
TABLE 49 NORTH AMERICA: PEN NEEDLES MARKET, BY COUNTRY,
2016–2023 (MILLION UNITS) 93
TABLE 50 NORTH AMERICA: PEN NEEDLES MARKET, BY TYPE, 2016–2023 (USD MILLION) 93
TABLE 51 NORTH AMERICA: PEN NEEDLES MARKET, BY TYPE, 2016–2023 (MILLION UNITS) 94
TABLE 52 NORTH AMERICA: PEN NEEDLES MARKET, BY NEEDLE LENGTH,
2016–2023 (USD MILLION) 94
TABLE 53 NORTH AMERICA: PEN NEEDLES MARKET, BY THERAPY,
2016–2023 (USD MILLION) 94
TABLE 54 NORTH AMERICA: PEN NEEDLES MARKET, BY MODE OF PURCHASE,
2016–2023 (USD MILLION) 95
TABLE 55 US: PEN NEEDLES MARKET, BY TYPE, 2016–2023 (USD MILLION) 96
TABLE 56 US: PEN NEEDLES MARKET, BY TYPE, 2016–2023 (MILLION UNITS) 96
TABLE 57 CANADA: PEN NEEDLES MARKET, BY TYPE, 2016–2023 (USD MILLION) 97
TABLE 58 CANADA: PEN NEEDLES MARKET, BY TYPE, 2016–2023 (MILLION UNITS) 97
TABLE 59 ASIA PACIFIC: PEN NEEDLES MARKET, BY COUNTRY, 2016–2023 (USD MILLION) 99
TABLE 60 ASIA PACIFIC: PEN NEEDLES MARKET, BY COUNTRY, 2016–2023 (MILLION UNITS) 99
TABLE 61 ASIA PACIFIC: PEN NEEDLES MARKET, BY TYPE, 2016–2023 (USD MILLION) 99
TABLE 62 ASIA PACIFIC: PEN NEEDLES MARKET, BY TYPE, 2016–2023 (MILLION UNITS) 100
TABLE 63 ASIA PACIFIC: PEN NEEDLES MARKET, BY NEEDLE LENGTH,
2016–2023 (USD MILLION) 100
TABLE 64 ASIA PACIFIC: PEN NEEDLES MARKET, BY THERAPY, 2016–2023 (USD MILLION) 100
TABLE 65 ASIA PACIFIC: PEN NEEDLES MARKET, BY MODE OF PURCHASE,
2016–2023 (USD MILLION) 101
TABLE 66 JAPAN: PEN NEEDLES MARKET, BY TYPE, 2016–2023 (USD MILLION) 101
TABLE 67 JAPAN: PEN NEEDLES MARKET, BY TYPE, 2016–2023 (MILLION UNITS) 102
TABLE 68 CHINA: PEN NEEDLES MARKET, BY TYPE, 2016–2023 (USD MILLION) 102
TABLE 69 CHINA: PEN NEEDLES MARKET, BY TYPE, 2016–2023 (MILLION UNITS) 103
TABLE 70 INDIA: PEN NEEDLES MARKET, BY TYPE, 2016–2023 (USD MILLION) 103
TABLE 71 INDIA: PEN NEEDLES MARKET, BY TYPE, 2016–2023 (MILLION UNITS) 104
TABLE 72 ROAPAC: PEN NEEDLES MARKET, BY TYPE, 2016–2023 (USD MILLION) 104
TABLE 73 ROAPAC: PEN NEEDLES MARKET, BY TYPE, 2016–2023 (THOUSAND UNITS) 104
TABLE 74 ROW: PEN NEEDLES MARKET, BY REGION, 2016–2023 (USD MILLION) 106
TABLE 75 ROW: PEN NEEDLES MARKET, BY REGION, 2016–2023 (MILLION UNITS) 106
TABLE 76 ROW: PEN NEEDLES MARKET, BY TYPE, 2016–2023 (USD MILLION) 106
TABLE 77 ROW: PEN NEEDLES MARKET, BY TYPE, 2016–2023 (THOUSAND UNITS) 107
TABLE 78 ROW: PEN NEEDLES MARKET, BY NEEDLE LENGTH, 2016–2023 (USD MILLION) 107
TABLE 79 ROW: PEN NEEDLES MARKET, BY THERAPY, 2016–2023 (USD MILLION) 107
TABLE 80 ROW: PEN NEEDLES MARKET, BY MODE OF PURCHASE,
2016–2023 (USD MILLION) 108
TABLE 81 LATIN AMERICA: PEN NEEDLES MARKET, BY TYPE, 2016–2023 (USD MILLION) 108
TABLE 82 LATIN AMERICA: PEN NEEDLES MARKET, BY TYPE,
2016–2023 (THOUSAND UNITS) 109
TABLE 83 MIDDLE EAST & AFRICA: PEN NEEDLES MARKET, BY TYPE,
2016–2023 (USD MILLION) 109
TABLE 84 MIDDLE EAST & AFRICA: PEN NEEDLES MARKET, BY TYPE,
2016–2023 (THOUSAND UNITS) 110
TABLE 85 PRODUCT LAUNCHES 115
TABLE 86 EXPANSIONS 116
TABLE 87 AGREEMENTS 116

LIST OF FIGURES

FIGURE 1 PEN NEEDLES MARKET SEGMENTATION 16
FIGURE 2 PEN NEEDLES MARKET: RESEARCH METHODOLOGY 18
FIGURE 3 RESEARCH DESIGN 19
FIGURE 4 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION,
AND REGION 22
FIGURE 5 MARKET SIZE ESTIMATION METHODOLOGY: BOTTOM-UP APPROACH 24
FIGURE 6 MARKET SIZE ESTIMATION METHODOLOGY: TOP-DOWN APPROACH 24
FIGURE 7 DATA TRIANGULATION METHODOLOGY 25
FIGURE 8 PEN NEEDLES MARKET, BY TYPE, 2018 27
FIGURE 9 PEN NEEDLES MARKET, BY LENGTH, 2018–2023 28
FIGURE 10 PEN NEEDLES MARKET, BY THERAPY, 2018–2023 28
FIGURE 11 PEN NEEDLES MARKET, BY MODE OF PURCHASE, 2018 29
FIGURE 12 GEOGRAPHIC SNAPSHOT: PEN NEEDLES MARKET, 2018 30
FIGURE 13 GROWING PREVALENCE OF CHRONIC DISEASES TO DRIVE THE GROWTH OF THE PEN NEEDLES MARKET 31
FIGURE 14 STANDARD PEN NEEDLES TO DOMINATE THE EUROPEAN PEN NEEDLES MARKET DURING THE FORECAST PERIOD 32
FIGURE 15 STANDARD PEN NEEDLES TO DOMINATE THE NORTH AMERICAN PEN NEEDLES MARKET DURING THE FORECAST PERIOD 33
FIGURE 16 ASIA PACIFIC IS EXPECTED TO GROW AT THE HIGHEST CAGR DURING THE FORECAST PERIOD 34
FIGURE 17 PEN NEEDLES MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, & CHALLENGES 35
FIGURE 18 PORTER’S FIVE FORCES ANALYSIS: PEN NEEDLES MARKET 39
FIGURE 19 SCORING METHODOLOGY 43
FIGURE 20 COMPARISONS OF COMPETITIVE INTENSITY SCORES: BD, NOVO NORDISK,
AND YPSOMED 49
FIGURE 21 RELATIVE POSITIONING OF COMPANIES BASED ON COMPETITIVE INTENSITY SCORE AND PEN NEEDLE FOCUS 50
FIGURE 22 SAFETY PEN NEEDLES BY BD AND STANDARD PEN NEEDLES BY NOVO NORDISK ARE PREMIUM-PRICED 51
FIGURE 23 BD HAS A ROBUST PORTFOLIO OF BOTH STANDARD AND SAFETY PEN NEEDLES 51
FIGURE 24 BD HAS A HIGHER FOCUS ON INNOVATION FOR ITS PEN NEEDLES BUSINESS 52
FIGURE 25 BD AND NOVO NORDISK HAVE A STRONG GEOGRAPHIC PRESENCE 53
FIGURE 26 BD AND NOVO NORDISK SHOWCASE HIGH FOCUS ON MARKETING & PROMOTIONAL ACTIVITIES 53
FIGURE 27 NOVO NORDISK HAS A HIGH FOCUS ON DIABETES EDUCATION & AWARENESS 54
FIGURE 28 NOVO NORDISK AGGRESSIVELY FOLLOWS THE STRATEGIES OF PARTNERSHIPS & AGREEMENTS 54
FIGURE 29 BD, NOVO NORDISK, AND YPSOMED EQUALLY EXHIBIT HIGH COMPLIANCE WITH INDUSTRY STANDARDS 55
FIGURE 30 STANDARD PEN NEEDLES TO COMMAND THE LARGEST SHARE OF THE PEN NEEDLES MARKET DURING THE FORECAST PERIOD 57
FIGURE 31 8MM PEN NEEDLES SEGMENT ACCOUNTED FOR THE LARGEST MARKET
SHARE IN 2018 63
FIGURE 32 INSULIN THERAPY SEGMENT TO COMMAND THE LARGEST SHARE OF THE PEN NEEDLES MARKET IN 2018 69
FIGURE 33 RETAIL SEGMENT WILL CONTINUE TO DOMINATE THE PEN NEEDLES MARKET DURING THE FORECAST PERIOD 76
FIGURE 34 EUROPE TO COMMAND THE LARGEST SHARE OF THE GLOBAL PEN NEEDLES MARKET IN 2018 81
FIGURE 35 EUROPE: PEN NEEDLES MARKET SNAPSHOT 83
FIGURE 36 NORTH AMERICA: PEN NEEDLES MARKET SNAPSHOT 92
FIGURE 37 ASIA PACIFIC: PEN NEEDLES MARKET SNAPSHOT 98
FIGURE 38 REST OF WORLD: PEN NEEDLES MARKET SNAPSHOT 105
FIGURE 39 PEN NEEDLES MARKET SHARE (AS OF 2017) 111
FIGURE 40 MNM DIVE-VENDOR COMPARISON MATRIX: PEN NEEDLES MARKET 114
FIGURE 41 STRATEGIES ADOPTED BY MARKET PLAYERS (2015-2018) 115
FIGURE 42 BECTON, DICKINSON AND COMPANY: COMPANY SNAPSHOT 117
FIGURE 43 NOVO NORDISK: COMPANY SNAPSHOT 119
FIGURE 44 YPSOMED: COMPANY SNAPSHOT 121
FIGURE 45 B.BRAUN: COMPANY SNAPSHOT 125
FIGURE 46 TERUMO: COMPANY SNAPSHOT 126

【免責事項】
※当レポート上の情報/データは調査会社が信頼できると判断した情報源から入手したものに基づき作成しましたが、その正確性・完全性を保証するものではありません。当レポートに記載された情報/データ/見解/仮説などは作成時点又は発行時点における調査会社の判断であり、その後の状況変化に応じて変更される場合があります。当レポート上の情報/データに基づいたお客様の意思決定又は実行による結果について、調査会社/発行会社/販売会社H&Iグローバルリサーチはその責を負いかねますのでご了承ください。英文資料の紹介ページにおける日本語題名/概要/目次はH&Iグローバルリサーチが翻訳した内容であり、翻訳の正確性・完全性を保証するものではありません。

[ペンニードルの世界市場予測（～2023年）]についてメールでお問い合わせはこちら

◆関連調査資料◆

細胞治療技術の世界市場予測（～2023年）
BT 6823 / MarketsandMarkets / 2018年12月21日 / 細胞治療技術の世界市場は、2018年の102億米ドルから2023年には199億米ドルに達し、この期間中14.4％の年平均成長率で成長すると予測されています。この市場の成長を促す要因として、細胞ベースの研究に対する政府の投資増加、GMP認証製造施設の増加、および腫瘍学を核とした細胞ベースの治療法・臨床試験などが考えられます。一方で、細胞ベースの研究の高コストと低い成功率が要因で、市場の成長は抑制される可能性があります。当調査レポートでは、細胞治療技術の世界市場について調査・分析し、エグゼクティブサマリー、市場インサイト、市場概観/市場動向、市場シェア分析、製品（消耗品、機器、ソフトウェア）分析、細胞の種類（ヒト幹細胞・分化細胞、動物細胞）分析、プロセス段階（細胞処理、細胞分配、細胞操作、品質管理）分析、エンドユーザー分析、細胞治療技術の世界市場規模及び予測、市場動向、競争状況、関連企業分析などの情報をお届けいたします。...“Global cell therapy instruments market to register a CAGR of 14.4% from 2018 to 2023”The global cell therapy instruments market is projected to reach USD 19.9 billion by 2023 from USD 10.2 billion in 2018, at a CAGR of 14.4% during the forecast period. Factors such as rising government investments for cell-based research, the increasing number of GMP-certified production facilities, and the large number of oncology-oriented cell-based therapy clinical trials are driving the growth of this market. However, the high cost of cell-based research and low success rate are expected to restrain market growth during the forecast period. “Consumables segment...

粒子線治療の世界市場予測（～2023年）
MD-6747 / MarketsandMarkets / 2018年11月16日 / 粒子線治療の世界市場は、2018年の8億6500万米ドルから2023年には13億4900万米ドルに達し、9.3％の年平均成長率で成長すると予測されています。この市場の成長を促す要因として、粒子線治療が光子療法よりも優れていること、世界中でがんの罹患率が拡大していること、臨床試験において粒子線治療の採用が増加していること、世界中で粒子線治療センターが増加していることなどが考えれられます。当調査レポートでは、粒子線治療の世界市場について調査・分析し、エグゼクティブサマリー、市場インサイト、市場概観/市場動向、産業動向、市場シェア分析、タイプ（重粒子イオン、陽子線治療）分析、製品（サイクロトロン、シンクロトロン、シンクロサイクロトロン）分析、サービス分析、システム（シングルルーム、マルチルーム）分析、粒子線治療の世界市場規模及び予測、市場動向、競争状況、関連企業分析などの情報をお届けいたします。...“The particle therapy market is projected to grow at a CAGR of 9.3% during the forecast period”The global particle therapy market is projected to reach USD 1,349 million by 2023 from USD 865 million in 2018, at a CAGR of 9.3%. The growth of this market is largely driven by factors such as the various advantages offered by particle therapy over photon therapy, growing global prevalence of cancer, increasing adoption of particle therapy in clinical trials, and the increasing number of particle therapy centers worldwide. “The cyclotrons segment is expected to account for the largest market share during the forecast...

疼痛の寒冷療法の世界市場予測（～2023年）
MD-4660 / MarketsandMarkets / 2018年6月7日 / MarketsandMarketsが発行した当調査レポートでは、疼痛の寒冷療法の世界市場について調査・分析し、エグゼクティブサマリー、市場インサイト、市場概観/市場動向、市場シェア分析、製品（OTC、処方ベース）別分析、用途別分析、地域別分析、疼痛の寒冷療法の世界市場規模及び予測、市場動向、競争状況、関連企業分析などの情報をお届けいたします。...“The cold pain therapy market is projected to grow at a CAGR of 4.6%.”The global cold pain therapy market is projected to reach USD 2.12 billion by 2023 from USD 1.69 billion in 2018, at a CAGR of 4.6%. The increasing incidence of sports injuries and rising emphasis on exercise and gym activities, growing number of hip and knee surgeries across the globe, and growing need for safer pain management modalities as opposed to oral drug therapy are expected to drive the demand for cold pain therapy products during the study period. On the other hand, lack of reimbursement and...

ペン型注射器の世界市場予測（～2022年）：タイプ別(使い捨て、再使用可能)、治療別(糖尿病(インスリン、グルカゴン様ペプチド-1 )、ホルモン補充、骨粗鬆症、不妊治療)、エンドユーザー別(ホームケア、病院)、地域別
MAM-MD-6041 / MarketsandMarkets / 2018年2月27日 / MarketsandMarketsが発行した当調査レポートでは、ペン型注射器の世界市場について調査・分析し、エグゼクティブサマリー、市場インサイト、市場概観/市場動向、市場シェア分析、ペン型注射器の世界市場規模及び予測、市場動向、競争状況、関連企業分析などの情報をお届けいたします。・イントロダクション・調査手法・エグゼクティブサマリー・プレミアムインサイト・ペン型注射器市場：タイプ別・ペン型注射器市場：治療方法別・ペン型注射器市場：エンドユーザー別・ペン型注射器市場：地域別・競争状況...“The injection pen market is projected to grow at a CAGR of 6.0% during the forecast period” The global injection pen market is expected to reach USD 41.38 billion by 2022 from an estimated USD 30.97 billion in 2017, at a CAGR of 6.0% during the forecast period. Growing prevalence of chronic diseases across the globe, increasing number of regulatory approvals, and favorable reimbursements are expected to drive the growth of the injection pen market. However, preference for alternative drug delivery modes and poor reimbursement scenario in developing countries is expected to restrain the growth of this market to a...

羊水穿刺用針の世界市場予測（～2022年）
MAM-MD-5843 / MarketsandMarkets / 2017年12月20日 / MarketsandMarketsが発行した当調査レポートでは、羊水穿刺用針の世界市場について調査・分析し、エグゼクティブサマリー、市場インサイト、市場概観/市場動向、市場シェア分析、種類別分析、処置別分析、需要先別分析、地域別分析、羊水穿刺用針の世界市場規模及び予測、市場動向、競争状況、関連企業分析などの情報をお届けいたします。...The global amniocentesis needle market is expected to reach USD 172.8 Million by 2022 from USD 150.6 Million in 2017, at a CAGR of 2.8%. The high reliability of the amniocentesis technique, rise in the median age of first-time motherhood, and increasing burden of congenital disorders are key factors driving the growth of this market. The global amniocentesis needle market is segmented by type, procedure, end user, and regions. By type, the amniocentesis needles market is segmented into needles of length 100–150 mm, larger than 150 mm, and smaller than 100 mm. The 100–150 mm segment is estimated to account...

医療用ニードル（注射針）の世界市場予測（～2022年）
MAM-MD5374 / MarketsandMarkets / 2017年6月26日 / 当調査レポートでは、医療用ニードル（注射針）の世界市場について調査・分析し、エグゼクティブサマリー、市場インサイト、市場概観/市場動向、種類別分析、製品別分析、材料別分析、需要先別分析、医療用ニードル（注射針）の世界市場規模及び予測、市場動向、競争状況、関連企業分析などの情報をお届けいたします。...The global needles market is projected to reach USD 8.47 Billion by 2022 from USD 5.82 Billion in 2017, at a CAGR of 7.8% during the forecast period. The growing geriatric population, increasing number of hospitals in emerging markets, high prevalence of chronic diseases, and increasing demand for vaccines are the major factors driving the growth of the needles market across the globe. This report broadly segments the needles market into type, products, material, delivery mode, and end user. On the basis of type, the global needles market is segmented into two broad categories, namely, conventional needles and safety needles....

インスリン送達デバイスの世界市場予測（～2021年）：インスリンペン型注入器、インスリンポンプ、注射針、インスリン注射器
MAM-MD5192 / MarketsandMarkets / 2017年4月24日 / 当調査レポートでは、インスリン送達デバイスの世界市場について調査・分析し、エグゼクティブサマリー、市場インサイト、市場概観/市場動向、市場シェア分析、種類別分析、需要先別分析、地域別分析、インスリン送達デバイスの世界市場規模及び予測、市場動向、競争状況、関連企業分析などの情報をお届けいたします。...The insulin delivery devices market is projected to reach USD 17.85 Billion by 2021 from 11.54 Billion in 2016, growing at a CAGR of 9.1% during the forecast period. The major drivers in the market include favorable reimbursement scenario and government support in selected countries, technological advancements in insulin delivery devices, and growing diabetic population. The global insulin delivery devices market is categorized on the basis of type, end user, and region. On the basis of type, the market is categorized into pens, pumps, pen needles, syringes, and other devices (jet injectors, transdermal patches, and inhalers). In 2016, the insulin...

ペンニードルの世界市場：種類、長さ、治療、購入、地域別分析
MD-2851 / MarketsandMarkets / 2016年6月24日 / 当調査レポートでは、ペンニードルの世界市場について調査・分析し、エグゼクティブサマリー、市場インサイト、市場概観/市場動向、市場シェア分析、市場環境分析、種類別分析、ニードルの長さ別分析、治療別分析、購入別分析、市場規模及び予測、市場動向、競争状況、関連企業分析などの情報をお届けいたします。...The pen needles market is expected to reach USD 2.81 Billion by 2021 from USD 1.65 Billion in 2016, growing at a CAGR of 11.2% from 2016 to 2021. The market is segmented on the basis of type, needle length, therapy, and mode of purchase. By type, the market is categorized into standard and safety pen needles. The standard pen needles segment is expected to account for the largest share of the market in 2016. The large share of this segment can be attributed to the low cost of these instruments and increasing adoption in emerging nations. However, the safety...

ヒトインスリンの世界市場：ヒトインスリン薬、ヒトインスリン・デリバリーデバイス
BT-3981 / MarketsandMarkets / 2016年1月4日 / 当調査レポートでは、ヒトインスリンの世界市場について調査・分析し、エグゼクティブサマリー、市場インサイト、市場概観/市場動向、産業動向、市場シェア分析、薬別分析、種類別分析、デリバリーデバイス別分析、用途別分析、市場規模及び予測、市場動向、競争状況、関連企業分析などの情報をお届けいたします。...The global human insulin market is poised to reach ~USD 39.13 Billion by 2020 growing at a CAGR of 8.1% from 2015 to 2020. Market growth can be attributed to factors such as growing diabetes patient population, increasing population exposure to key risk factors leading to diabetes, rising market demand for human insulin analogs, technological advancements in the field of human insulin delivery devices, and favorable medical reimbursements. However, stringent regulatory requirements for product approval are restraining the growth of market. In addition, high product manufacturing costs is posing significant challenges for market growth. On the basis of product, the...

ペンニードル（ペン型注入器用注射針）の世界市場：標準型ペンニードル、安全型ペンニードル、針長別分析、療法別分析
MAM-MD-2851 / MarketsandMarkets / 2014年10月30日 / ...Over the years, the pen needles market has witnessed various technological advancements in order to cater to the growing demand of safety injections in the healthcare industry. These advancements have led to development of safety pen needles with an aim to reduce pain, increase comfort, and most importantly reduce needlestick injuries (NSIs). The standard pen needles segment accounts for the largest share of the global pen needles market, by type, while 6mm pen needles accounted for the largest share of the pen needles market, by needle length. Insulin therapy account for major share of the pen needles market, by therapy...

◆H&Iグローバルリサーチ株式会社のお客様（例）◆